Showing results (21-30 of 72) with videos related to
Sort By:
Pageof 8
Journal of Clinical Pharmacology|October 8, 2010
Clinical pharmacokinetics of tonapofylline: evaluation of dose proportionality, oral bioavailability, and gender and food effects in healthy human subjectsZhaoyang Li, Christopher TenHoor, Thomas Marbury, et al.Clinical Pharmacokinetics|May 21, 2010
Renal insufficiency has no effect on the pharmacokinetics of vicriviroc in a ritonavir-containing regimenClaudia Kasserra, Angela Sansone-Parsons, Anther Keung, et al.Journal of Clinical Pharmacology|October 21, 2020
Pharmacokinetics of Voxelotor in Patients With Renal and Hepatic ImpairmentRichard A Preston, Thomas Marbury, Ganesh Balaratnam, et al.Clinical Pharmacokinetics|January 26, 2026
Pharmacokinetics and Safety of a Single Dose of Brensocatib in Participants with Hepatic Impairment and Matched Participants with Normal Hepatic FunctionsHelen Usansky, Sam Au Yeung, Sherry Li, et al.Journal of Clinical Pharmacology|April 12, 2019
Characterization of the Effect of Hepatic Impairment on Upadacitinib PharmacokineticsSheryl Trueman, Mohamed-Eslam F Mohamed, Tian Feng, et al.Journal of Cancer|June 16, 2023
Pharmacokinetics and Safety of Multiple-Dose Alpelisib in Participants with Moderate or Severe Hepatic Impairment: A Phase 1, Open-Label, Parallel Group StudyThomas Marbury, Mona El-Hashimy, Lars Blumenstein, et al.Journal of Clinical Pharmacology|December 27, 2016
Pharmacokinetics of a Single Oral Dose of the MEK1/2 Inhibitor Selumetinib in Subjects With End-Stage Renal Disease or Varying Degrees of Hepatic Impairment Compared With Healthy SubjectsAngela W Dymond, Paul Martin, Karen So, et al.British Journal of Clinical Pharmacology|June 9, 2007
Multiple-dose pharmacokinetics of peginterferon alfa-2b in patients with renal insufficiencySamir K Gupta, Suzanne K Swan, Thomas Marbury, et al.Clinical Pharmacokinetics|June 10, 2011
Asenapine pharmacokinetics in hepatic and renal impairmentPierre Peeters, Howard Bockbrader, Edwin Spaans, et al.British Journal of Clinical Pharmacology|October 19, 2013
Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate renal impairmentKarthik Venkatakrishnan, Yi Liu, Dennis Noe, et al.Pageof 8